Talk Business & Politics: In defense of PBMs
June 20, 2019
Simply put, the core mission for PBMs is to be the primary advocate for consumers and health plans in the...
Filter by:
Choose a Topic
Filter by Year:Clear Filters- Highlights
- Biosimilars
- Drug Abuse Prevention
- Drug Cost Management
- Drug Coupons & Assistance Programs
- Drug Coverage Mandates
- Drug Price Negotiations & Rebates
- Formulary Design
- Fraud, Waste, & Abuse
- Generic Drug Utilization
- Home Delivery of Drugs
- Mark Merritt
- Medicaid
- Medicare Part D
- Patient Cost Sharing
- Pharmacy Networks
- Pharmacy Reimbursement & Contracting
- Specialty Pharmacies
- TRICARE
Medium: PBM Expertise Crucial to Success of Potential New Rebate System in Medicare and Medicaid
May 30, 2019
PBMs are an important link in the drug supply and payment chain that includes manufacturers, wholesalers, physicians, pharmacies and Pharmacy...
Morning Consult: PBMs Set the Record Straight on Value to Consumers
May 06, 2019
Appearing recently before the Senate Finance Committee, executives for pharmacy benefit managers had the opportunity to set the record straight...
Morning Consult: New Medicare Prescription Drug Rebate Rule: Wrong Solution to High Drug Prices
March 06, 2019
Prescription drug list prices in the United States continue to be a source of frustration for patients and policymakers alike....
November 14, 2018
The drug giants moved in near-perfect synchronicity, raising prices for their top-selling arthritis treatments as though they were opposite-corner gas...
Morning Consult: Will the Trump Drug-Pricing Initiative Wreck the Medicare Part D Success Story?
November 09, 2018
First, rebates are directly responsible for lowering Part D premiums and program spending....
The Cleveland Plain Dealer: Corral Ohio’s Medicaid ‘Pac-Man’
October 09, 2018
Ohio Medicaid takes better advantage of the expansive industry relationships and pharmacy networks that PBMs have built to provide patients...
Pittsburgh Post-Gazette: We must make prescription drugs affordable
October 09, 2018
PBMs are projected to save $654 billion dollars on drug costs on behalf of 266 million Americans...
Kaiser Health News: Drugmakers Play The Patent Game To Lock In Prices, Block Competitors
October 03, 2018
FDA Commissioner Scott Gottlieb calls “patent thickets,” claiming multiple patents for a single drug to build protection from competitors....
Forbes: Abolishing Drug Rebates May Push Consumer Drug Costs Higher
September 27, 2018
In fact, there is considerable evidence that rebates help reduce drug costs...
The Washington Post: Rebates aren’t the problem. Drug companies’ prices are
September 04, 2018
The president has made it very clear he wants the same thing Americans want: for drug companies to lower their...
August 22, 2018
“The administration understands … PBMs are part of the solution,” Merritt said....